Convenio Medicamentos Parenterales y Anestesicos
Abastecer de fármacos ante posibles quiebres de stock CENABAST para entregar atención oportuna, eficiente y eficaz de los pacientes tratados en el HTC
13 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058037-84-SE23 | 07-03-2023 | Laboratorio Sanderson S.A. | $321.300 |
| 1058037-68-SE23 | 14-02-2023 | Laboratorio Biosano S.A. | $152.796 |
| 1058037-55-SE23 | 27-01-2023 | Laboratorio Biosano S.A. | $142.800 |
| 1058037-53-SE23 | 27-01-2023 | Laboratorio Sanderson S.A. | $343.434 |
| 1058037-319-SE22 | 30-12-2022 | Laboratorio Biosano S.A. | $142.800 |
| 1058037-314-SE22 | 30-12-2022 | Laboratorio Sanderson S.A. | $59.500 |
| 1058037-304-SE22 | 07-12-2022 | Laboratorio Sanderson S.A. | $428.400 |
| 1058037-284-SE22 | 14-11-2022 | Laboratorio Biosano S.A. | $154.700 |
| 1058037-282-SE22 | 14-11-2022 | Laboratorio Sanderson S.A. | $374.850 |
| 1058037-246-SE22 | 04-10-2022 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-111-SE22 | 04-10-2022 | Laboratorio Sanderson S.A. | $27.846 |
| 1058037-200-SE22 | 24-08-2022 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-189-SE22 | 08-08-2022 | Laboratorio Biosano S.A. | $188.020 |
| 1058037-179-SE22 | 01-08-2022 | Laboratorio Biosano S.A. | $235.025 |
| 1058037-162-SE22 | 21-07-2022 | Laboratorio Sanderson S.A. | $22.610 |
| 1058037-140-SE22 | 24-06-2022 | Laboratorio Sanderson S.A. | $33.915 |
| 1058037-135-SE22 | 15-06-2022 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-122-SE22 | 03-06-2022 | Laboratorio Sanderson S.A. | $33.915 |
| 1058037-116-SE22 | 23-05-2022 | Laboratorio Sanderson S.A. | $22.610 |
| 1058037-112-SE22 | 17-05-2022 | Laboratorio Sanderson S.A. | $374.850 |
| 1058037-93-SE22 | 02-05-2022 | Laboratorio Sanderson S.A. | $14.756 |
| 1058037-92-SE22 | 02-05-2022 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-79-SE22 | 12-04-2022 | Laboratorio Sanderson S.A. | $22.610 |
| 1058037-44-SE22 | 07-03-2022 | Grifols Chile S.A. | $921.358 |
| 1058037-35-SE22 | 25-02-2022 | Laboratorio Sanderson S.A. | $22.610 |
| 1058037-34-SE22 | 25-02-2022 | Laboratorio Biosano S.A. | $178.500 |
| 1058037-9-SE22 | 24-01-2022 | Grifols Chile S.A. | $460.679 |
| 1058037-4-SE22 | 07-01-2022 | Aventis Pharma Holding Gmbh | $485.520 |
| 1058037-408-SE21 | 21-12-2021 | Laboratorio Sanderson S.A. | $37.366 |
| 1058037-394-SE21 | 10-12-2021 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-395-SE21 | 10-12-2021 | Opko Chile S.A. | $710.430 |
| 1058037-296-SE21 | 29-07-2021 | Aventis Pharma Holding Gmbh | $485.520 |
| 1058037-259-SE21 | 12-07-2021 | Laboratorio Sanderson S.A. | $33.915 |
| 1058037-235-SE21 | 24-06-2021 | Opko Chile S.A. | $236.810 |
| 1058037-215-SE21 | 11-06-2021 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-202-SE21 | 02-06-2021 | Aventis Pharma Holding Gmbh | $242.760 |
| 1058037-178-SE21 | 18-05-2021 | Opko Chile S.A. | $710.430 |
| 1058037-170-SE21 | 14-05-2021 | Laboratorio Sanderson S.A. | $31.535 |
| 1058037-160-SE21 | 05-05-2021 | Laboratorio Sanderson S.A. | $110.670 |
| 1058037-135-SE21 | 23-04-2021 | Opko Chile S.A. | $473.620 |
| 1058037-123-SE21 | 15-04-2021 | Opko Chile S.A. | $236.810 |
| 1058037-109-SE21 | 05-04-2021 | Laboratorio Sanderson S.A. | $92.225 |
| 1058037-107-SE21 | 31-03-2021 | Laboratorio Sanderson S.A. | $29.512 |
| 1058037-98-SE21 | 19-03-2021 | Laboratorio Sanderson S.A. | $29.512 |
| 1058037-99-SE21 | 19-03-2021 | Opko Chile S.A. | $473.620 |
| 1058037-93-SE21 | 16-03-2021 | Laboratorio Sanderson S.A. | $114.835 |
Fuente original:ficha mercadopublico.cl
